Restatement of Quarterly Financial Information (Unaudited) - Schedule of Restatement of Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)		3 Months Ended							6 Months Ended	9 Months Ended	12 Months Ended
	Oct. 01, 2024	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Jun. 30, 2024	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net Loss		$ (43,704,000)	$ (30,966,000)	$ (47,162,000)	$ (328,235,000)	$ (800,000)	$ (100,000)	$ (0)	$ (375,397,000)	$ (406,363,000)	$ (450,067,000)	$ (261,906,000)	$ (8,888,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization					22,390,000				44,843,000	67,894,000	90,529,000	112,949,000	67,553,000
Asset impairment											0	0	17,433,000
Goodwill impairment	$ 0	0	0	0	297,353,000				297,353,000	297,353,000	297,353,000	37,874,000	0
Amortization of debt issuance cost					1,013,000				1,013,000	1,013,000	3,950,000	862,000	288,000
(Accretion) amortization on available-for-sale investments, net												(22,000)	19,000
(Gain) loss on investments					(2,621,000)				(2,867,000)	(4,238,000)	(5,030,000)	(2,900,000)	9,826,000
Net loss on disposal of property, plant and equipment					150,000				185,000	203,000	1,371,000	458,000	152,000
Stock-based compensation expense					3,954,000				7,787,000	11,482,000	15,988,000	16,381,000	28,322,000
Deferred income taxes					(19,738,000)				(13,684,000)	(13,399,000)	5,576,000	15,724,000	(62,388,000)
Other, net					545,000				(126,000)	(267,000)		(2,942,000)
Inventory write down - business efficiency program					3,992,000				4,135,000	4,135,000	4,135,000	24,313,000
Inventory reserves					1,837,000				3,722,000	6,667,000	5,316,000	25,546,000	(2,363,000)
Change in operating assets and liabilities:
Accounts receivable, net					22,504,000				23,415,000	59,446,000	46,108,000	72,320,000	788,000
Other receivables					5,605,000				6,279,000	4,875,000	10,713,000	10,315,000	(20,088,000)
Income taxes receivable, net					(3,439,000)				(918,000)	(947,000)	648,000	2,098,000
Inventory					32,366,000				64,407,000	73,887,000	79,985,000	22,408,000	(73,237,000)
Prepaid expenses, other current assets and other assets					(19,290,000)				(18,139,000)	(22,164,000)	(13,445,000)	(31,964,000)	(7,116,000)
Accounts payable					553,000				(3,966,000)	9,697,000	10,238,000	(91,907,000)	28,105,000
Accrued expenses and other liabilities					10,953,000				22,645,000	15,034,000	4,873,000	11,317,000	(20,483,000)
Income taxes payable, net					1,155,000				(2,878,000)	(3,175,000)	(4,670,000)	(3,939,000)	(2,151,000)
Net cash provided by (used in) operating activities					37,925,000				57,809,000	101,133,000	103,571,000	(43,015,000)	(44,228,000)
Cash flows from investing activities:
Purchases of property, plant and equipment					(13,510,000)				(24,971,000)	(31,168,000)	(34,501,000)	(36,337,000)	(17,072,000)
Purchases of intangibles - developed technology					(1,191,000)				(5,725,000)	(19,669,000)	(30,671,000)	(9,438,000)
Proceeds from sales and maturities of available-for-sale investments					873,000				956,000	1,195,000	1,240,000	10,567,000	51,661,000
Purchases of available-for-sale investments					(44,000)				(121,000)	(195,000)	(268,000)	(868,000)	(23,899,000)
Proceeds from beneficial interests in securitized accounts receivable										282,000
Net cash (used in) provided by investing activities					(13,872,000)				(29,861,000)	(49,555,000)	(64,255,000)	(34,858,000)	55,831,000
Cash flows from financing activities:
Tax withholdings related to stock-based compensation settlements					(176,000)				(189,000)	(189,000)	(1,143,000)	(6,458,000)	(4,253,000)
Proceeds from stock option exercises					219,000				219,000	219,000	824,000	540,000	6,904,000
Dividend payments											0	(21,237,000)	(22,885,000)
Proceeds from receivables purchase agreement					30,231,000				68,556,000	68,556,000	68,556,000	14,099,000
Repayments on receivables purchase agreement					(32,437,000)				(66,399,000)	(83,772,000)	(83,772,000)
Proceeds from draw on revolving credit agreements											26,000,000	163,733,000	141,887,000
Repayment of revolving credit agreements									(5,000,000)	(5,000,000)	(31,000,000)	(64,987,000)	(48,000,000)
Payment for redemption of redeemable non-controlling interest					(5,000)				(25,000)	(17,395,000)	(17,398,000)	(1,224,000)
Payment of annual recurring compensation to non-controlling interest										(10,084,000)	(10,084,000)
Payment of debt issuance cost					(1,994,000)				(1,994,000)	(1,994,000)	(1,994,000)	(708,000)	(3,015,000)
Repayment of notes payable									0			(24,891,000)	(17,702,000)
Net cash (used in) provided by financing activities					(4,162,000)				(4,832,000)	(49,659,000)	(50,011,000)	58,867,000	52,936,000
Net (decrease) increase in cash and cash equivalents					19,891,000				23,116,000	1,919,000	(10,695,000)	(19,006,000)	64,539,000
Effect of exchange rate changes					(301,000)				902,000	(630,000)	(451,000)	(2,471,000)	(12,713,000)
Cash, cash equivalents and restricted cash, beginning of year	88,456,000	88,456,000	111,185,000	106,757,000	87,167,000				87,167,000	87,167,000	87,167,000	108,644,000	56,818,000
Cash, cash equivalents and restricted cash, end of year		76,021,000	88,456,000	111,185,000	106,757,000	108,644,000			111,185,000	88,456,000	76,021,000	87,167,000	108,644,000
Supplemental disclosure of cash financing activities:
Cash paid for interest					5,243,000				6,554,000	18,225,000	20,884,000	12,596,000	1,728,000
Cash paid for income taxes					2,315,000				7,433,000	9,122,000	6,691,000	18,552,000	3,832,000
Cash used in operating activities related to operating leases					2,384,000				4,780,000	7,380,000	9,274,000	9,682,000	5,229,000
Supplemental disclosure of non-cash investing activities
Right-of-use assets obtained in exchange for lease obligations					842,000				1,999,000	2,122,000	5,317,000	17,865,000	3,410,000
Purchases of property, plant and equipment included in accounts payable					1,689,000				1,059,000	952,000	2,635,000	1,298,000	1,165,000
Redemption of redeemable non-controlling interest										2,976,000	2,986,000	371,000
As Reported [Member]
Cash flows from operating activities:
Net Loss		(43,510,000)	(28,857,000)	(47,011,000)	(321,670,000)				(368,681,000)	(397,538,000)	(441,048,000)	(259,343,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization					22,528,000				45,156,000	68,421,000	90,985,000	112,949,000
Goodwill impairment		0	0	0	292,583,000				292,583,000	292,583,000	292,583,000	37,874,000
Amortization of debt issuance cost					1,013,000				1,013,000	1,013,000	3,950,000	862,000
(Accretion) amortization on available-for-sale investments, net												(22,000)
(Gain) loss on investments					(2,621,000)				(2,867,000)	(4,238,000)	(5,030,000)	(2,900,000)
Net loss on disposal of property, plant and equipment					150,000				185,000	203,000	1,371,000	458,000
Stock-based compensation expense					3,957,000				7,793,000	11,417,000	15,342,000	16,016,000
Deferred income taxes					(19,738,000)				(13,684,000)	(13,399,000)	2,247,000	15,558,000
Other, net					545,000				(126,000)	(267,000)		(2,942,000)
Inventory write down - business efficiency program					3,992,000				4,135,000	4,135,000	4,135,000	24,313,000
Inventory reserves					1,837,000				3,722,000	6,667,000	3,980,000	25,546,000
Change in operating assets and liabilities:
Accounts receivable, net					26,002,000				26,913,000	59,446,000	46,108,000	65,612,000
Other receivables					5,605,000				6,279,000	4,875,000	10,713,000	10,315,000
Income taxes receivable, net					(1,296,000)				(5,653,000)	(5,682,000)	648,000	(2,637,000)
Inventory					30,426,000				62,151,000	69,412,000	75,171,000	20,537,000
Prepaid expenses, other current assets and other assets					(15,882,000)				(14,731,000)	(20,083,000)	(10,718,000)	(29,883,000)
Accounts payable					553,000				(3,966,000)	9,697,000	11,784,000	(91,907,000)
Accrued expenses and other liabilities					7,459,000				19,152,000	15,039,000	5,519,000	17,929,000
Income taxes payable, net					1,155,000				(2,878,000)	(3,175,000)	(4,670,000)	(3,939,000)
Net cash provided by (used in) operating activities					36,598,000				56,496,000	98,526,000	103,070,000	(45,604,000)
Cash flows from investing activities:
Purchases of property, plant and equipment					(12,183,000)				(23,644,000)	(28,514,000)	(32,454,000)	(33,683,000)
Purchases of intangibles - developed technology					(1,191,000)				(5,725,000)	(19,669,000)	(30,671,000)	(9,438,000)
Proceeds from sales and maturities of available-for-sale investments					873,000				956,000	1,195,000	1,240,000	10,567,000
Purchases of available-for-sale investments					(44,000)				(121,000)	(195,000)	(268,000)	(868,000)
Proceeds from beneficial interests in securitized accounts receivable										282,000
Net cash (used in) provided by investing activities					(12,545,000)				(28,534,000)	(46,901,000)	(62,208,000)	(32,204,000)
Cash flows from financing activities:
Tax withholdings related to stock-based compensation settlements					(176,000)				(189,000)	(189,000)	(1,143,000)	(6,458,000)
Proceeds from stock option exercises					219,000				219,000	219,000	824,000	540,000
Dividend payments												(21,237,000)
Proceeds from receivables purchase agreement					30,231,000				68,556,000	68,556,000	68,556,000	14,099,000
Repayments on receivables purchase agreement					(32,437,000)				(66,399,000)	(83,772,000)	(83,772,000)
Proceeds from draw on revolving credit agreements											26,000,000	163,733,000
Repayment of revolving credit agreements									(5,000,000)	(5,000,000)	(31,000,000)	(64,987,000)
Payment for redemption of redeemable non-controlling interest					(5,000)				(25,000)	(17,395,000)	(17,398,000)	(1,224,000)
Payment of annual recurring compensation to non-controlling interest										(10,084,000)	(10,084,000)
Payment of debt issuance cost					(1,994,000)				(1,994,000)	(1,994,000)	(1,994,000)	(708,000)
Repayment of notes payable									0			(24,891,000)
Net cash (used in) provided by financing activities					(4,162,000)				(4,832,000)	(49,659,000)	(50,011,000)	58,867,000
Net (decrease) increase in cash and cash equivalents					19,891,000				23,130,000	1,966,000	(9,149,000)	(18,941,000)
Effect of exchange rate changes					(301,000)				888,000	(677,000)	(451,000)	(2,536,000)
Cash, cash equivalents and restricted cash, beginning of year	$ 88,456,000	88,456,000	111,185,000	106,757,000	87,167,000				87,167,000	87,167,000	87,167,000	108,644,000
Cash, cash equivalents and restricted cash, end of year		77,567,000	88,456,000	111,185,000	106,757,000	$ 108,644,000			111,185,000	88,456,000	77,567,000	87,167,000	$ 108,644,000
Supplemental disclosure of cash financing activities:
Cash paid for interest					5,243,000				6,554,000	18,225,000	20,884,000	12,596,000
Cash paid for income taxes					2,315,000				7,433,000	9,122,000	6,691,000	18,552,000
Cash used in operating activities related to operating leases					2,384,000				4,780,000	7,380,000	9,274,000	9,682,000
Supplemental disclosure of non-cash investing activities
Right-of-use assets obtained in exchange for lease obligations					842,000				1,999,000	2,122,000	5,317,000	17,865,000
Purchases of property, plant and equipment included in accounts payable					1,689,000				1,059,000	952,000	2,635,000	1,298,000
Redemption of redeemable non-controlling interest										2,976,000	2,986,000	371,000
Adjustment [Member]
Cash flows from operating activities:
Net Loss		(194,000)	(2,109,000)	(151,000)	(6,565,000)				(6,716,000)	(8,825,000)	(9,019,000)	(2,563,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization					(138,000)				(313,000)	(527,000)	(456,000)
Goodwill impairment		0	$ 0	$ 0	4,770,000				4,770,000	4,770,000	4,770,000
Stock-based compensation expense					(3,000)				(6,000)	65,000	646,000	365,000
Deferred income taxes											3,329,000	166,000
Inventory reserves											1,336,000
Change in operating assets and liabilities:
Accounts receivable, net					(3,498,000)				(3,498,000)			6,708,000
Income taxes receivable, net					4,735,000				(4,735,000)	4,735,000		4,735,000
Inventory					1,940,000				(2,256,000)	4,475,000	4,814,000	1,871,000
Prepaid expenses, other current assets and other assets					3,408,000				3,408,000	2,081,000	(2,727,000)	(2,081,000)
Accounts payable									0		(1,546,000)
Accrued expenses and other liabilities					3,494,000				3,493,000	(5,000)	(646,000)	(6,612,000)
Net cash provided by (used in) operating activities					1,327,000				1,313,000	(2,607,000)	501,000	2,589,000
Cash flows from investing activities:
Purchases of property, plant and equipment					(1,327,000)				1,327,000	2,654,000	2,047,000	(2,654,000)
Purchases of intangibles - developed technology					0				0	0
Net cash (used in) provided by investing activities					$ (1,327,000)				(1,327,000)	(2,654,000)	(2,047,000)	(2,654,000)
Cash flows from financing activities:
Net (decrease) increase in cash and cash equivalents									(14,000)	(47,000)	(1,546,000)	(65,000)
Effect of exchange rate changes									$ 14,000	$ 47,000		$ 65,000
Cash, cash equivalents and restricted cash, end of year		$ (1,546,000)									$ (1,546,000)